Peptide compound for inhibiting restenosis and promoting re-endothelialization and method for preparing the same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9603893
APP PUB NO 20160228621A1
SERIAL NO

15139977

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are a peptide compound prepared by additional synthesis in a drug having an effect of inhibiting restenosis, a composition for inhibiting restenosis and promoting re-endothelialization including the peptide compound, and a stent having a surface coated by using the composition, in order to overcome a restenosis problem in the stent.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHONNAM NATIONAL UNIVERSITY HOSPITAL42 JEBONG-RO DONG-GU GWANGJU 501-757

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bae, In-Ho Gwangju, KR 7 11
Jang, Eun Jae Gwangju, KR 8 11
Jeong, Myung Ho Gwangju, KR 14 20
Lee, So Youn Gwangju, KR 13 28
Lim, Kyung Seob Gwangju, KR 12 11
Park, Dae Sung Gwangju, KR 31 49

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 28, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00